Tag Archives: Norovirus

Integrated Environmental Technologies, Ltd – New EPA Approved Amended Label For Excelyte® Incorporates Kill Claims for Adenovitus,Norovirus,Rhinovirus,Rotavirus

ietlogo3

 

Integrated Environmental Technologies, Ltd. announced that the U.S. Environmental Protection Agency (EPA) approved an amendment to the Company’s master label for its Excelyte® disinfecting solution.

The Company’s new EPA-approved label incorporates kill claims for adenovirus, norovirus, rhinovirus and rotavirus, which are considered non-enveloped viruses

The Company’s amended EPA-approved label for Excelyte® will continue to include previously EPA-approved kill claims for: (i) various pathogens including, but not limited to, Mycobacterium bovis (Tuberculosis), Salmonella enterica, Pseudomonas aeruginosa, Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), H1N1 influenza virus (swine flu) and Respiratory Syncytial virus (RSV); (ii)  hospital-acquired pathogens such as Clostridium difficile spores (C. diff) and vancomycin-resistant enterococci (VRE) as well as a carbapenem-resistant enterobacteriaceae (CRE) known as Klebsiella pneumoniae (NDM-1); (iii)  high-risk blood-borne pathogen human immunodeficiency virus (HIV); (iv) the food-borne pathogens Listeria monocytogenes and Escherichia coli (E. coli); and (v) Yeast, Candida albicans.

These viruses have resulted in serious problems for chain restaurants, cruise ships, and other establishments operating in the food, health or hospitality industries.

Non-enveloped viruses are more resistant to disinfectants than enveloped viruses, many of which are already listed on the Company’s master label.  EPA registered hospital disinfectants such as Excelyte® that have claims against non-enveloped viruses are capable of killing both enveloped and non-enveloped viruses on non-porous environmental surfaces.  This group of viruses can cause serious gastrointestinal, stomach, respiratory and eye infections in humans who have been exposed.

Norovirus is highly contagious and is spread through contaminated food, water and environmental surfaces.  Norovirus infections have been an ongoing challenge in the food, healthcare and hospitality industries and recent outbreaks in chain restaurants and cruise lines have underlined the need to eradicate these viral infections.

Although the Company is currently focused on selling Excelyte® to the oil and gas production industry, the amended EPA label will provide increased opportunities for the use of Excelyte® in the food, healthcare and hospitality industries.  The Company continues to seek strategic partners to assist in the development, marketing and distribution of Excelyte® into these markets.

David R. LaVance, the Company’s President and Chief Executive Officer, commented, “We have pursued the addition of these non-enveloped viruses due to the serious and deadly outbreaks that have been reported nationally and internationally over the past few years.  Norovirus, in particular, has caused significant problems for a major fast food chain.  With the increasing ineffectiveness of antibiotics, it is important to use antibacterial products, such as Excelyte®, to eliminate pathogens before they infect people.”

About Integrated Environmental Technologies, Ltd.

Integrated Environmental Technologies, Ltd. is a publicly-traded company that operates through its wholly-owned operating subsidiary, I.E.T., Inc.  All of the Company’s products and services are marketed and sold under the umbrella brand name, EcoTreatments.

The Company markets and sells its anolyte disinfecting solution under the Excelyte® brand name, which is produced by the Company’s proprietary EcaFlo® equipment that utilizes an electrolytic process known as electrochemical activation to reliably produce environmentally responsible solutions for cleaning, sanitizing and disinfecting.

Excelyte® solutions are EPA-registered, hard-surface disinfectants and sanitizers approved for hospital-level use and are also approved for use as a biocide in the oil and gas industry.  The products can be used anywhere there is a need to control bacteria and viruses. 

The Company’s EcaFlo® equipment also produces a cleaning solution that the Company markets under the Catholyte Zero brand name.  Catholyte Zero solutions are environmentally friendly cleansers and degreasers for janitorial, sanitation and food processing uses.  To learn more, visit www.ecotreatments.com.

To read the article in its entirety please click on the following link:

http://money.cnn.com/news/newsfeeds/articles/prnewswire/PH84506.htm

 

 

 

Children’s Hospital in Los Angeles California Introduces New High-Tech Disinfecting Robots

Xenex_LogoLockups_PantoneC

 

 

Half a million square feet. More than 350 beds. And tomorrow, they clean it all over again. Every day, Environmental Services  staff members work to disinfect every surface in Children’s Hospital Los Angeles, playing a crucial behind-the-scenes role in preventing infections and keeping patients safe. Now, on top of scrubbing, spraying, mopping and wiping, they can add another action – zapping.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150915006821/en/

“Cleaning is a fundamental function of any healthcare facility, and our housekeepers may go unnoticed because their work disinfecting the hospital often happens before patients even get to their rooms,” says Jill Hoffman, MD, a pediatric infectious disease specialist and medical director of infection prevention and control at Children’s Hospital Los Angeles. “We arm our doctors and nurses with high-tech tools and surgical robots, and now we are doing the same for those on the front line of our battle against infections.”

As hospitals across the country look for new, innovative ways to battle pathogens and multi-drug resistant organisms that put patients at risk, and as flu season draws closer, CHLA has introduced four new non-human team members that can annihilate potentially lethal germs and bacteria lurking in hard-to-reach places.

CHLA’s four new Xenex Germ-Zapping Robots™ – affectionately named Charlie, Ziggy, Phoenix and R2Clean2 – use pulsed xenon ultraviolet (UV-C) light, thousands of times more powerful than sunlight, to quickly destroy harmful bacteria, viruses, fungi and even bacterial spores. The portable disinfection system takes about 20 minutes per room – for a total of about an hour when combined with traditional cleaning techniques – and is effective against even the most dangerous pathogens, including Clostridium difficile (C-diff), norovirus, influenza and methicillin-resistant Staphylococcus aureus (MRSA).

Supplementing the work of more than 200 top-notch EVS/housekeeping staff, this new technology gives CHLA another tool to provide hospitalized infants, children and young adults the safest experience possible.

“Adding another layer of protection to our already robust infection prevention protocols allows us to be even more proactive in protecting our patients,” says Hoffman. “Children’s Hospital Los Angeles is nationally and internationally recognized for patient care, and even one hospital-acquired infection is one too many. These robots can help us advance towards our goal of zero infections.”

In fact, during a brief trial run with a Xenex robot earlier this year, CHLA was able to see a 10 percent reduction in infection rates in areas of the hospital tested. Other hospitals that have used the robots for longer periods have reported even more dramatic reductions – more than 50 percent in some cases – in C. diff and MRSA rates.